Vivos Therapeutics, Inc.VVOS财报
Nasdaq · biotechnology
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| Armistice Capital, LLC | 4.99% | 250.3K | ▼ -5.00pp | 2024-11-14 |
| Coronado V Partners, LLC | 3.20% | 69.6K | — | 2024-02-14 |
| Ionic Ventures, LLC | 1.80% | 83.0K | ▼ -6.90pp | 2024-11-14 |
内部人交易
Net 90d: +$1.81M · buys $1.81M / sells $0时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 1.04M | $1.34 | $1.40M |
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 308.8K | $1.34 | $413.9K |
1–2 of 2